1. Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome 
Kitsada Wudhikarn, Claudio G. Brunstein, Veronika Bachanova, Linda J. Burns, Qing Cao, Daniel J. Weisdorf 
Biology of Blood and Marrow Transplantation 
Volume 17, Issue 10, Pages (October 2011)
DOI: /j.bbmt
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) OS after allogeneic HCT; (B) 3-year survival following relapse after allogeneic HCT; (C) OS following allogeneic HCT in early (<100 days) versus late relapse.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Survival after allogeneic HCT. (A) Responders CR/PR vsersus SD/PD. (B) Histologic subsets. (C) Stage at relapse (stage I-III versus IV). (D) Site of relapse (nodes versus extranodal versus combined sites).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions